Novel brings broad expertise and infrastructure across a range of pharmaceutical applications, suitable for a variety of therapeutic classes and categories. We have an excellent track in developing and commercializing high barrier to entry products. These barriers to entry may include intellectual property protection, complex manufacturing processes or specialized equipment demands, regulatory challenges, packaging issues and advanced analytical methodology requirements.

Our capabilities can be accessed in a variety of ways, depending on partner needs therapeutic classes and dosage forms. For more information on what we do, please see our Capabilities page.